Shares of Docusign Inc. (NASDAQ:DOCU - Get Free Report) have earned an average rating of "Hold" from the sixteen research firms that are covering the company, Marketbeat Ratings reports. Twelve investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $89.77.
A number of analysts recently issued reports on the company. William Blair reaffirmed an "outperform" rating on shares of Docusign in a research report on Monday, April 21st. UBS Group lowered their price target on Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Wedbush lowered their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research report on Thursday, June 12th. Hsbc Global Res raised Docusign from a "moderate sell" rating to a "hold" rating in a research report on Friday, April 11th. Finally, HSBC raised Docusign from a "reduce" rating to a "hold" rating and set a $70.00 price target on the stock in a research report on Friday, April 11th.
Check Out Our Latest Report on DOCU
Insider Activity at Docusign
In related news, Director Teresa Briggs sold 534 shares of the business's stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $74.37, for a total value of $39,713.58. Following the completion of the sale, the director directly owned 8,805 shares in the company, valued at approximately $654,827.85. The trade was a 5.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the sale, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. This represents a 24.08% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,552 shares of company stock worth $3,491,951. Company insiders own 1.01% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the stock. Banque Transatlantique SA bought a new stake in Docusign during the 1st quarter valued at $26,000. Hemington Wealth Management grew its stake in shares of Docusign by 318.1% during the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares during the last quarter. Golden State Wealth Management LLC boosted its holdings in shares of Docusign by 519.4% during the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after purchasing an additional 322 shares during the period. Summit Securities Group LLC purchased a new stake in shares of Docusign during the first quarter worth about $34,000. Finally, Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign during the fourth quarter worth about $37,000. 77.64% of the stock is owned by institutional investors.
Docusign Price Performance
Shares of Docusign stock opened at $78.97 on Friday. The firm has a market cap of $15.96 billion, a price-to-earnings ratio of 14.93, a price-to-earnings-growth ratio of 28.79 and a beta of 1.08. The stock's 50-day moving average is $82.28 and its 200-day moving average is $84.69. Docusign has a one year low of $48.80 and a one year high of $107.86.
Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The business had revenue of $763.65 million for the quarter, compared to the consensus estimate of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%. Docusign's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.82 earnings per share. On average, equities analysts expect that Docusign will post 1.17 EPS for the current year.
Docusign announced that its Board of Directors has initiated a stock repurchase plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to purchase up to 6.6% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its stock is undervalued.
Docusign Company Profile
(
Get Free ReportDocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.